HEALTH

Altria takes a $4.5 billion hit on Juul amid vaping backlash

Nov 1, 2019, 6:07 AM
FILE - In this Dec. 20, 2018, file photo Juul products are displayed at a smoke shop in New York. A...
FILE - In this Dec. 20, 2018, file photo Juul products are displayed at a smoke shop in New York. Altria swung to a loss in the third quarter as it wrote down the value of its investment in e-cigarette maker Juul. Altria bought roughly a third of Juul for $13 billion last December. Since then, an outbreak of vaping illnesses - some deadly - has led to multiple investigations, with Juul no longer advertising its products in the U.S. (AP Photo/Seth Wenig, File)
(AP Photo/Seth Wenig, File)

WASHINGTON (AP) — Marlboro-maker Altria is taking a big financial hit from its multibillion-dollar bet on e-cigarettes.

The tobacco giant on Thursday slashed the value of its investment in the beleaguered vaping company Juul Labs by a third, dragging down its results to a financial loss for the quarter.

Richmond, Virginia-based Altria bought roughly a third of Juul for $13 billion last December. But executives said they would take a $4.5 billion write-down on the investment amid a growing crackdown on Juul and the vaping industry at large.

Since last year, Juul has been hit by new federal and state investigations into its marketing amid an explosion of underage vaping among teenagers. Separately, an outbreak of lung injuries tied to vaping has led to new government warnings around e-cigarettes. No single product or ingredient has been identified as the root cause.

Altria executives said the cut to Juul’s value reflects recent vaping bans by state and local authorities and expected restrictions from the federal government. The U.S. Food and Drug Administration is expected to soon outline new restrictions on vaping flavors, a step intended to curb youth appeal.

Juul has made a number of voluntary concessions in an effort to weather the firestorm, including halting product advertising and pulling several of its flavored products .

A lawsuit filed in California earlier this week by a former Juul executive leveled new allegations against the company, including that it disregarded quality procedures and knowingly shipped of tainted mint-flavored pods to customers.

Juul called the lawsuit “baseless.” And the company’s former CEO, Kevin Burns, rejected the account.

“As CEO, I had the company make huge investments in product quality, and the facts will show this claim is absolutely false and pure fiction,” said Burns, through a spokesperson. Burns was replaced as CEO last month by K.C. Crosthwaite, an executive from Altria.

In a regulatory filing Thursday, Altria revealed that the Federal Trade Commission is investigating the company’s role in the resignation of Burns and “the hiring by Juul of any current or former Altria director, executive or employee.”

Under the management shake-up this month, Crosthwaite announced that another Altria executive, Joe Murillo, would become Juul’s chief regulatory officer. Murillo previously worked as Altria’s head of regulatory affairs.

Altria Group Inc. said it posted a quarterly loss of $2.6 billion, or $1.39 per share, for the period ended Sept. 30. Those results included the $4.5 billion pretax write-down of Juul. Adjusted earnings of $1.19 per share beat the average Street estimate of $1.14 per share, based on an analyst survey by Zacks.

Altria, the maker of Marlboro cigarettes and Copenhagen chew, has been working to shift its business away from traditional tobacco amid steady declines in smoking.

The company recently began selling a heat-not-burn cigarette alternative, iQOS , made by Philip Morris International. Altria is marketing the first-of-a-kind device in the U.S. under a licensing deal with the international tobacco maker. Both companies say the device could appeal to smokers who have been unwilling to switch to vaping products, which use a nicotine solution, not tobacco.

Altria, which owns Philip Morris USA, said total revenue was virtually flat at $6.86 billion. Its adjusted revenue, which excludes excise taxes, totaled $5.41 billion and beat estimates.

The company still expects to earn $4.19 to $4.27 per share for the full year, representing growth of 5% to 7% over last year. It lowered its long-term growth target of 7% to 9% to a new range of 5% to 8% growth for 2020 through 2022.

Shares in Altria Group Inc. ended Thursday down $1.17, or 2.6%, to $44.79.

___

This story has been corrected to show that adjusted earnings per share in the latest quarter totaled $1.19, not $1.08.

Today’s Top Stories

Health

Utah homes are recording high levels of radon gas. 
Photo credit: Laura Seitz, Deseret News...
Heather Kelly and Elizabeth Weiler

Utah homes have some of the highest levels of radon gas

New research finds that Utah homes have the 5th highest levels of radon gas when compared to the rest of the nation. The U.S. Environmental Protection Agency (EPA) found that one in 15 homes in the U.S. have dangerous levels of radon gas. Utah is at much higher risk, as the agency found one in […]
12 hours ago
Image of the semi-truck that broke through the concrete barrier and rolled into the embankment (Pho...
Chandler Holt

Semi driver dies after driving off side of roadway

A semi drove off the right side of the road, breaking through the concrete barrier, on US-6 at milepost 185 in Spanish Fork canyon.
12 hours ago
WWE Essential...
Zoe Sottile, CNN

John Cena breaks Make-A-Wish record after granting 650 wishes

Actor, wrestling legend, and perpetual meme subject John Cena has completed a new accomplishment: breaking the world record for most wishes granted through the Make-A-Wish Foundation.
3 days ago
Utah Republicans are looking to ban transgender surgeries and other hormone-based care....
Mark Jones

Utah to receive additional $4.9 million from FEMA in response to COVID-19

FEMA has announced Utah will receive an additional $4.9 million to help with the housing costs during the COVID-19 pandemic.
4 days ago
BYU tracking...
Simone Seikaly

BYU researchers learn importance of tracking, in fitness and other goals

BYU researchers found that tracking an activity helps to increase (or decrease) that activity.
6 days ago
anxiety...
Adam Small

National health panel recommends anxiety screenings for adults under 65

Anxiety screenings were recommended for adults 19 to 64 by the task force to help combat the under-detection of anxiety disorders.
7 days ago

Sponsored Articles

a worker with a drill in an orange helmet installs a door in the house...
Price's Guaranteed Doors

Home improvement tip: Increase the value of your home by weatherproofing doors

Make sure your home is comfortable before the winter! Seasonal maintenance keeps your home up to date. Read our tips on weatherproofing doors.
Curb Appeal...
Price's Guaranteed Doors

How to have the best of both worlds for your house | Home security and curb appeal

Protect your home and improve its curb appeal with the latest security solutions like beautiful garage doors and increased security systems.
A paper reading IRS, internal revenue service is pictured...
Jordan Wilcox

The best strategies for dealing with IRS tax harassment | You have options!

Learn how to deal with IRS tax harassment. This guide will teach you how to stop IRS phone calls and letters, and how to handle an IRS audit.
spend a day at Bear Lake...
Bear Lake Convention and Visitors Bureau

You’ll love spending the day at Bear Lake | How to spend a day at Bear Lake

Bear Lake is a place that needs to be experienced. Spend a day at Bear Lake.
Prescription opioids can be disposed of during National Prescription Take Back Day...
Know Your Script

Prescription opioid misuse | How to protect your family from the opioid epidemic

Studies have shown that prescription opioid misuse has increased since COVID-19. So what do you need to know about these opioids?
national heart month...
Intermountain Healthcare

National Heart Month: 5 Lifestyle Changes to Make Today to Keep You Heart Healthy

Heart disease is the leading cause of death for both men and women. One person dies every 36 seconds in the United States from cardiovascular disease
Altria takes a $4.5 billion hit on Juul amid vaping backlash